Tectonic Therapeutic | AVRO - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Celltrion KRW 434.82B 1.14B 2026-03
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
MacroGenics USD 21.2M 34.39M 2026-03
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 371.81M 2.36M 2026-03
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pfizer USD 90.1B 3.63B 2026-03
Pharma Mar EUR 249.67M 2.16M 2026-03
Qiagen NV USD 3.78B 128.73M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 72.81B 1.1B 2026-03
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Sartorius EUR 2.73B 1.14B 2026-03
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Takeda JPY 7.77T 129.5B 2026-03
Tilray USD 1.58B 39.08M 2025-09
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03